A vaccine update — Pfizer and Moderna told Congress this week they will deliver (a combined) 140 million more doses to the U.S. market over the next five weeks.
If approved this weekend, J&J has said it will distribute at least 20 million single-dose shots by the end of March.
If approved this weekend, J&J has said it will distribute at least 20 million single-dose shots by the end of March.
In total, with these three shots, the U.S. will have enough supply to fully vaccinate 90 million more people by April 1. 21.6 million people have already received both doses of either Pfizer or Moderna. At least 111.6 million with antibody protection by the end of the 1st quarter
Canada will have enough vaccines on hand to fully vaccinate 3 million people by the end of March, based on current approvals. J&J and AstraZeneca could get the green light any day now. But, clearly, Canada is lagging.
The U.S. is expected to have enough supply to vaccinate 4.5x more people, per capita, than Canada in the first three months of 2021. (7.89% vaccinated in Canada; 34% vaccinated in the U.S.)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
